Molecular Formula | C9H12N4O2 |
Molar Mass | 208.22 |
Density | 1.278±0.06 g/cm3(Predicted) |
Boling Point | 422.8±40.0 °C(Predicted) |
Solubility | Chloroform; Methanol |
Appearance | Solid |
Color | Yellow |
pKa | 8.50±0.10(Predicted) |
Storage Condition | under inert gas (nitrogen or Argon) at 2–8 °C |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 4.803 ml | 24.013 ml | 48.026 ml |
5 mM | 0.961 ml | 4.803 ml | 9.605 ml |
10 mM | 0.48 ml | 2.401 ml | 4.803 ml |
5 mM | 0.096 ml | 0.48 ml | 0.961 ml |
Use | 1-(6-nitropyridin-3-yl) piperazine is used as an intermediate for the treatment of breast cancer drug pembrocoxib, and 1-(6-nitropyridin-3-yl) piperazine is a key structural fragment for the synthesis of pembrocoxib. |